Bioasis Announces Issuance of US Patent Relating to xB³™ Platform Technology for The Delivery of Therapeutic Agents Across the Blood-Brain Barrier
October 20, 2020 16:05 ET
|
Bioasis Technologies Inc.
GUILFORD, Conn., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Bioasis Technologies Inc. (TSX.V:BTI; OTCQB:BIOAF) (the “Company” or “Bioasis”), a pre-clinical, research-stage biopharmaceutical company...
biOasis Announces Nominees to the Board of Directors, Chairman Transition and Details of its Annual General Meeting of Shareholders
August 28, 2017 08:00 ET
|
biOasis Technologies Inc.
VANCOUVER, BC--(Marketwired - August 28, 2017) - BIOASIS TECHNOLOGIES INC. (OTCQB: BIOAF)(TSX VENTURE: BTI) is pleased to announce its slate of nominees to the board of directors (the "Board") for...
biOasis Appoints Doug Williams, MBA, Executive Vice President, Chief Business Officer
August 21, 2017 08:00 ET
|
biOasis Technologies Inc.
VANCOUVER, BC--(Marketwired - August 21, 2017) - BIOASIS TECHNOLOGIES INC. (OTCQB: BIOAF) (TSX VENTURE: BTI) welcomes Doug Williams, MBA, as executive vice president, chief business officer, effective...
biOasis Appoints Catherine London, Executive Vice President, Head of Corporate Communications and Investor Relations
June 25, 2017 14:22 ET
|
biOasis Technologies Inc.
VANCOUVER, BC--(Marketwired - June 25, 2017) - BIOASIS TECHNOLOGIES INC. (OTCQB: BIOAF) (TSX VENTURE: BTI) welcomes Catherine London as executive vice president, head of corporate communications and...
biOasis Engages FreeMind Group to Access Non-Dilutive Global Funding Opportunities
June 15, 2017 00:24 ET
|
biOasis Technologies Inc.
VANCOUVER, BC--(Marketwired - June 15, 2017) - biOasis Technologies Inc. (OTCQB: BIOAF) (TSX VENTURE: BTI) announced today it has engaged FreeMind Group to assist the Company pursue non-dilutive...
biOasis CEO Dr. Mark Day Releases Details of Corporate Plans in Message to Shareholders
June 13, 2017 22:04 ET
|
biOasis Technologies Inc.
VANCOUVER, BC--(Marketwired - June 13, 2017) - BIOASIS TECHNOLOGIES INC. (OTCQB: BIOAF) (TSX VENTURE: BTI) Dr. Mark Day, chief executive officer, has issued a message to shareholders detailing plans...
biOasis to Present at The Global Chinese Financial Forum - Shanghai Conference 2017
June 08, 2017 23:16 ET
|
biOasis Technologies Inc.
VANCOUVER, BC--(Marketwired - June 08, 2017) - BIOASIS TECHNOLOGIES INC. (OTCQB: BIOAF) (TSX VENTURE: BTI) announced today that Dr. Mark Day, the chief executive officer of biOasis, will present at...
biOasis to Present at the 16th International Postgraduate Course on Lysosomal Storage Disorders
June 04, 2017 21:00 ET
|
biOasis Technologies Inc.
VANCOUVER, BC--(Marketwired - June 04, 2017) - BIOASIS TECHNOLOGIES INC. (OTCQB: BIOAF) (TSX VENTURE: BTI) announced today that Dr. Mark Day, chief executive officer, will present at the 16th...
biOasis Appoints Mark Day, Ph.D., as Chief Executive Officer and Director
April 24, 2017 17:07 ET
|
biOasis Technologies Inc.
VANCOUVER, BC--(Marketwired - April 24, 2017) - THIS NEWS RELEASE IS NOT FOR DISSEMINATION IN THE UNITED STATES BIOASIS TECHNOLOGIES INC. (OTCQB: BIOAF) (TSX VENTURE: BTI) (the "Company") has...
biOasis Closes Oversubscribed Non-Brokered Private Placement
April 11, 2017 20:12 ET
|
biOasis Technologies Inc.
VANCOUVER, BC--(Marketwired - April 11, 2017) - NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESBIOASIS TECHNOLOGIES INC. (OTCQB: BIOAF) (TSX VENTURE:...